Original Research

Page 54

Original Research

Disability After Injury: The Cumulative Burden of Physical and Mental Health

February 15, 2013

Meaghan L. O' Donnell, Tracey Varker, Alexander C. Holmes, et al

Original Research

Effects of Cigarette Smoking on Neuropsychological Performance in Mood Disorders: A Comparison Between Smoking and Nonsmoking Inpatients

February 15, 2013

Daniela Caldirola, Silvia Daccò, Massimiliano Grassi, et al

Original Research

Efficacy and Safety of Desvenlafaxine 50 mg/d for Prevention of Relapse in Major Depressive Disorder: A Randomized Controlled Trial

February 15, 2013

Joshua Z. Rosenthal, Patrice Boyer, Cécile Vialet, et al

Original Research

Antipsychotic Drugs, Mood Stabilizers, and Risk of Pneumonia in Bipolar Disorder: A Nationwide Case-Control Study

January 15, 2013

Shu-Yu Yang, Ya-Tang Liao, Hsing-Cheng Liu, et al

Original Research

Effectiveness of Lurasidone in Patients with Schizophrenia or Schizoaffective Disorder Switched From Other Antipsychotics: A Randomized, 6-Week, Open-Label Study

January 15, 2013

Joseph P. McEvoy, Leslie Citrome, David Hernandez, et al

Original Research

Four-Year Outcome in Psychopharmacologically Treated Adults With Attention-Deficit/Hyperactivity Disorder: A Questionnaire Survey

January 15, 2013

Michael B. Lensing, Pål Zeiner, Leiv Sandvik, et al

Original Research

Quantitative Electroencephalogram Biomarkers for Predicting Likelihood and Speed of Achieving Sustained Remission in Major Depression: A Report From the Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD) Trial

January 15, 2013

Ian A. Cook, Aimee M. Hunter, William S. Gilmer, et al

Original Research

Substance Induced Schizophrenia

January 15, 2013

Read a study investigating the rate of SIP conversion to schizophrenia spectrum disorder.

Jussi A. Niemi-Pynttäri, Reijo Sund, Hanna Putkonen, et al

Original Research

Trends in Office-Based Treatment of Adults With Stimulants in the United States

January 15, 2013

Mark Olfson, Carlos Blanco, Shuai Wang, et al

Original Research

The Daytime Impactof DSM-5 Insomnia Disorder: Comparative Analysis of Insomnia Subtypes From the Great British Sleep Survey

December 15, 2012

Colin A. Espie, Simon D. Kyle, Peter Hames, et al

Original Research

Effects of Co-Occurring Depression on Treatment for Anxiety Disorders: Analysis of Outcomes From a Large Primary Care Effectiveness Trial

December 15, 2012

Laura Campbell-Sills, Cathy D. Sherbourne, Peter Roy-Byrne, et al

Original Research

Phenotypic Differences Between Pregnancy-Onset and Postpartum-Onset Major Depressive Disorder

December 15, 2012

Margaret Altemus, Christine C. Neeb, Alida Davis, et al

Original Research

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Safety, and Tolerability of Extended-Release Metadoxine in Adults With Attention-Deficit/Hyperactivity Disorder

December 15, 2012

Iris Manor, Rachel Ben-Hayun, Judith Aharon-Peretz, et al

Original Research

Response to Past Depression Treatments Is Not Accurately Recalled: Comparison of Structured Recall and Patient Health Questionnaire Scores in Medical Records

December 15, 2012

Gregory E. Simon, Carolyn M. Rutter, Christine Stewart, et al

Original Research

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

December 15, 2012

George I. Papakostas, Ottavio V. Vitolo, Waguih W. IsHak, et al

Original Research

Comparison of Longer-Term Safety and Effectiveness of 4 Atypical Antipsychotics in Patients Over Age 40: A Trial Using Equipoise-Stratified Randomization

November 27, 2012

Hua Jin, Pei-an Betty Shih, Shahrokh Golshan, et al

Original Research

Adjunctive Oral Ziprasidone in Patients With Acute Mania Treated With Lithium or Divalproex, Part 2: Influence of Protocol-Specific Eligibility Criteria on Signal Detection

November 15, 2012

Gary S. Sachs, Douglas G. Vanderburg, Suzanne Edman, et al

Original Research

Adjunctive Oral Ziprasidone in Patients With Acute Mania Treated With Lithium or Divalproex, Part 1: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

November 15, 2012

Gary S. Sachs, Douglas G. Vanderburg, Onur N. Karayal, et al

Original Research

Childhood Sexual Abuse and Psychiatric Disorders in Middle-Aged and Older Adults: Evidence From the 2007 Adult Psychiatric Morbidity Survey

November 15, 2012

Kee-Lee Chou

Original Research

Obsessive-Compulsive Symptoms in Patients With Schizophrenia: A Naturalistic Cross-Sectional Study Comparing Treatment With Clozapine, Olanzapine, Risperidone, and No Antipsychotics in 543 Patients

November 15, 2012

Albertine A. Scheltema Beduin, Marije Swets, Marise Machielsen, et al

Original Research

The Utility of Attention-Deficit/Hyperactivity Disorder Screening Instruments in Individuals Seeking Treatment for Substance Use Disorders

November 15, 2012

Elias Dakwar, Amy Mahony, Martina Pavlicova, et al

Original Research

Gabapentin Lawsuit Among Patients with Bipolar

October 16, 2012

Read our full evaluation on the $430 million gabapentin off-label marketing lawsuit and how it affected patients diagnosed with bipolar disorder.

Meredith J. Chace, Fang Zhang, Catherine A. Fullerton, et al

Original Research

Oral Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study

October 16, 2012

Danial Khajavi, Mehdi Farokhnia, Amirhossein Modabbernia, et al

Original Research

The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies

October 16, 2012

Guy Griebel, Sandra Beeské, Stephen M. Stahl

« 1 … 52 53 54 55 56 … 159 »

Original Research

Disability After Injury: The Cumulative Burden of Physical and Mental Health

Effects of Cigarette Smoking on Neuropsychological Performance in Mood Disorders: A Comparison Between Smoking and Nonsmoking Inpatients

Efficacy and Safety of Desvenlafaxine 50 mg/d for Prevention of Relapse in Major Depressive Disorder: A Randomized Controlled Trial

Antipsychotic Drugs, Mood Stabilizers, and Risk of Pneumonia in Bipolar Disorder: A Nationwide Case-Control Study

Effectiveness of Lurasidone in Patients with Schizophrenia or Schizoaffective Disorder Switched From Other Antipsychotics: A Randomized, 6-Week, Open-Label Study

Four-Year Outcome in Psychopharmacologically Treated Adults With Attention-Deficit/Hyperactivity Disorder: A Questionnaire Survey

Quantitative Electroencephalogram Biomarkers for Predicting Likelihood and Speed of Achieving Sustained Remission in Major Depression: A Report From the Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD) Trial

Substance Induced Schizophrenia

Trends in Office-Based Treatment of Adults With Stimulants in the United States

The Daytime Impactof DSM-5 Insomnia Disorder: Comparative Analysis of Insomnia Subtypes From the Great British Sleep Survey

Effects of Co-Occurring Depression on Treatment for Anxiety Disorders: Analysis of Outcomes From a Large Primary Care Effectiveness Trial

Phenotypic Differences Between Pregnancy-Onset and Postpartum-Onset Major Depressive Disorder

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Safety, and Tolerability of Extended-Release Metadoxine in Adults With Attention-Deficit/Hyperactivity Disorder

Response to Past Depression Treatments Is Not Accurately Recalled: Comparison of Structured Recall and Patient Health Questionnaire Scores in Medical Records

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

Comparison of Longer-Term Safety and Effectiveness of 4 Atypical Antipsychotics in Patients Over Age 40: A Trial Using Equipoise-Stratified Randomization

Adjunctive Oral Ziprasidone in Patients With Acute Mania Treated With Lithium or Divalproex, Part 2: Influence of Protocol-Specific Eligibility Criteria on Signal Detection

Adjunctive Oral Ziprasidone in Patients With Acute Mania Treated With Lithium or Divalproex, Part 1: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Childhood Sexual Abuse and Psychiatric Disorders in Middle-Aged and Older Adults: Evidence From the 2007 Adult Psychiatric Morbidity Survey

Obsessive-Compulsive Symptoms in Patients With Schizophrenia: A Naturalistic Cross-Sectional Study Comparing Treatment With Clozapine, Olanzapine, Risperidone, and No Antipsychotics in 543 Patients

The Utility of Attention-Deficit/Hyperactivity Disorder Screening Instruments in Individuals Seeking Treatment for Substance Use Disorders

Gabapentin Lawsuit Among Patients with Bipolar

Oral Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study

The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies

ELSEWHERE:

FOLLOW US:

Original Research

Disability After Injury: The Cumulative Burden of Physical and Mental Health

Effects of Cigarette Smoking on Neuropsychological Performance in Mood Disorders: A Comparison Between Smoking and Nonsmoking Inpatients

Efficacy and Safety of Desvenlafaxine 50 mg/d for Prevention of Relapse in Major Depressive Disorder: A Randomized Controlled Trial

Antipsychotic Drugs, Mood Stabilizers, and Risk of Pneumonia in Bipolar Disorder: A Nationwide Case-Control Study

Effectiveness of Lurasidone in Patients with Schizophrenia or Schizoaffective Disorder Switched From Other Antipsychotics: A Randomized, 6-Week, Open-Label Study

Four-Year Outcome in Psychopharmacologically Treated Adults With Attention-Deficit/Hyperactivity Disorder: A Questionnaire Survey

Quantitative Electroencephalogram Biomarkers for Predicting Likelihood and Speed of Achieving Sustained Remission in Major Depression: A Report From the Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD) Trial

Substance Induced Schizophrenia

Trends in Office-Based Treatment of Adults With Stimulants in the United States

The Daytime Impactof DSM-5 Insomnia Disorder: Comparative Analysis of Insomnia Subtypes From the Great British Sleep Survey

Effects of Co-Occurring Depression on Treatment for Anxiety Disorders: Analysis of Outcomes From a Large Primary Care Effectiveness Trial

Phenotypic Differences Between Pregnancy-Onset and Postpartum-Onset Major Depressive Disorder

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Safety, and Tolerability of Extended-Release Metadoxine in Adults With Attention-Deficit/Hyperactivity Disorder

Response to Past Depression Treatments Is Not Accurately Recalled: Comparison of Structured Recall and Patient Health Questionnaire Scores in Medical Records

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

Comparison of Longer-Term Safety and Effectiveness of 4 Atypical Antipsychotics in Patients Over Age 40: A Trial Using Equipoise-Stratified Randomization

Adjunctive Oral Ziprasidone in Patients With Acute Mania Treated With Lithium or Divalproex, Part 2: Influence of Protocol-Specific Eligibility Criteria on Signal Detection

Adjunctive Oral Ziprasidone in Patients With Acute Mania Treated With Lithium or Divalproex, Part 1: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Childhood Sexual Abuse and Psychiatric Disorders in Middle-Aged and Older Adults: Evidence From the 2007 Adult Psychiatric Morbidity Survey

Obsessive-Compulsive Symptoms in Patients With Schizophrenia: A Naturalistic Cross-Sectional Study Comparing Treatment With Clozapine, Olanzapine, Risperidone, and No Antipsychotics in 543 Patients

The Utility of Attention-Deficit/Hyperactivity Disorder Screening Instruments in Individuals Seeking Treatment for Substance Use Disorders

Gabapentin Lawsuit Among Patients with Bipolar

Oral Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study

The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles